PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP Inhibition

✍ Scribed by Ibrahim, Y. H.; Garcia-Garcia, C.; Serra, V.; He, L.; Torres-Lockhart, K.; Prat, A.; Anton, P.; Cozar, P.; Guzman, M.; Grueso, J.; Rodriguez, O.; Calvo, M. T.; Aura, C.; Diez, O.; Rubio, I. T.; Perez, J.; Rodon, J.; Cortes, J.; Ellisen, L. W.; Scaltriti, M.; Baselga, J.

• Book ID: 115517294
• Publisher: American Association for Cancer Research
• Year: 2012
• Tongue: English
• Weight: 610 KB
• Volume: 2
• Category: Article
• ISSN: 2159-8274
• DOI: 10.1158/2159-8290.cd-11-0348